Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-015039
Filing Date
2013-11-19
Accepted
2013-11-19 17:13:57
Documents
14
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q epct20130930_10q.htm 10-Q 1430554
2 EXHIBIT 10.2 ex10-2.htm EX-10 70446
3 EXHIBIT 10.3 ex10-3.htm EX-10 78233
4 EXHIBIT 10.4 ex10-4.htm EX-10 431322
5 EXHIBIT 31.1 ex31-1.htm EX-31 11557
6 EXHIBIT 31.2 ex31-2.htm EX-31 11632
7 EXHIBIT 32.1 ex32-1.htm EX-32 6688
8 EXHIBIT 32.2 ex32-2.htm EX-32 6712
  Complete submission text file 0001437749-13-015039.txt   11249318

Data Files

Seq Description Document Type Size
9 EXHIBIT 101.INS imnp-20130930.xml EX-101.INS 1595082
10 EXHIBIT 101.SCH imnp-20130930.xsd EX-101.SCH 99748
11 EXHIBIT 101.CAL imnp-20130930_cal.xml EX-101.CAL 29546
12 EXHIBIT 101.DEF imnp-20130930_def.xml EX-101.DEF 438654
13 EXHIBIT 101.LAB imnp-20130930_lab.xml EX-101.LAB 739354
14 EXHIBIT 101.PRE imnp-20130930_pre.xml EX-101.PRE 435247
Mailing Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51290 | Film No.: 131230790
SIC: 2834 Pharmaceutical Preparations